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Eberconazole nitrate (EBZ) is an imidazole derivative
(Sweetman, 2009), used topically as a 1% cream in the treatment
of superﬁcial fungal infections (Barbanoj et al., 2005). EBZ(Fig. 1), {1-(2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclo-
hepten-5-yl)-1H-Imidazole nitrate}, acts by inhibition of fun-
gal lanosterol 14a-demethylase (Torres-Rodrı´guez et al.,
1999). It is a basic, white, amorphous powder which is readily
soluble in methanol and dichloromethane. The absorption
maximum in the ultraviolet range is 208 nm. Fig. 2 shows
the absorption spectrum of EBZ (5 lg mL1; molar absorptiv-
ity: 7.06 · 104 L mol1 cm1).
Literature review reveals that there is no HPLC method re-
ported for analysis of EBZ, but there are several methods
available for the estimation of other azole antifungal agents
namely ﬂuconazole, itraconazole, voriconazole, posaconazole,
ravuconazole and isavuconazole. Chromatographic methods
available for these antifungal agents were reviewed (Ekiert
et al., 2010). In the modern analytical laboratory, there is al-
ways a need for signiﬁcant stability-indicating methods (SIMs)
Figure 2 UV absorption spectrum of EBZ in methanol.
Figure 1 Chemical structure of Eberconazole nitrate (EBZ).
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buffer species, ionic strength, light, oxygen, moisture, additives
and excipients, can play an important role in the stability of
drug substances. Stress testing can help in identifying degrada-
tion products and provide important information about the
intrinsic stability of drug substances (Singh and Bakshi,
2000). With the advent of the International Conference on
Harmonization (ICH) guidelines (ICH guideline Q1A (R2),
2003), requirements for the establishment of SIMs have be-
come more clearly mandated. The guidelines explicitly require
the conduct of forced decomposition studies under a variety of
conditions, like pH, light, oxidation, dry heat, etc. and separa-
tion of drug from degradation products. The method is ex-
pected to allow analysis of individual degradation products.
Moreover, kinetic studies on the decomposition of drugs using
stability testing techniques are essential for their quality con-
trol and to predict the expiry date of pharmaceutical products.
The scientiﬁc novelty of the present work is that the suggested
method represents the ﬁrst stability indicating HPLC method
for the analysis of EBZ. Besides, it is the ﬁrst kinetic study
for EBZ degradation to calculate the strength of this azole
molecule.
A response surface methodology (RSM) approach was used
to identify the optimum conditions for analysis during methoddevelopment. The iterative procedure used in these studies in-
cluded performing experiments in the region of the best known
solution, ﬁtting a response model to the experimental data and
then optimizing the estimated response model. The conven-
tional practice of modiﬁcation of a single factor at a time
may result in poor optimization as other factors are
maintained at constant levels that do not depict the combined
effect of all the factors involved in a separation. This approach
is also time consuming and requires a vast number of
experiments to establish optimum levels. These limitations
can be eliminated by collectively optimizing all parameters
using RSM. Furthermore RSM was used to evaluate the
relative signiﬁcance of several other factors in the presence
of complex interactions. Compared with the traditional
optimization method, RSM has distinct advantages such as
the use of minimum number of experiments, shorter time of
operation and feasibility of generating data that may be ana-
lyzed statistically to provide valuable information on the inter-
actions among experimental parameters. These designs are
rotatable (or near rotatable) and require three levels for each
factor. Diagrams of global optimum, which are more direct,
were made (Iuliani et al., 2010).
Experimental design approach has been applied to optimize
HPLC experimental conditions, such as the resolution and
time of analysis for pramipexole in tablets (Srinubabu et al.,
2006) and for the determination and optimization of vorico-
nazole in pharmaceutical formulations (Srinubabu et al.,
2007). Experimental design was used to optimize a liquid chro-
matographic method for the separation of six compounds
(Harang et al., 2001) and for the separation of the components
of a cough syrup (De Beer et al., 1996). The liquid chromato-
graphic separation of fosinopril sodium and its degradation
product, fosinoprilat was optimized using an experimental de-
sign (Biljana et al., 2005). A capillary electrophoresis method
was developed using the experimental design to separate
trandolapril and verapamil (Capella-Peiroa et al., 2007).
HPLC–ECD method was developed for the analysis of capto-
pril using experimental design (Khamanga and Walker, 2011).
HPLC method was developed using experimental design for
the determination of tetranortriterpenoids in Carapa guianen-
sis seed oil (Tappin et al., 2008).
The objective of this work was to develop a simple, sensi-
tive, precise and accurate HPLC method for EBZ that could
be applied to the stress degradation kinetics.2. Materials and methods
2.1. Chemicals, reagents and solutions
Pharmaceutical grade eberconazole nitrate was gifted by
Dr. Reddy’s Laboratories Ltd. (Hyderabad, India). Methanol
(HPLC grade) was purchased from Merck Chemical Company
(India). Potassium dihydrogen orthophosphate, tetra butyl
ammonium hydroxide (TBAH) and o-phosphoric acid, hydro-
chloric acid, sodium hydroxide, and 30% hydrogen peroxide
used were of analytical grade and purchased from S D Fine
Chem. Ltd. (Mumbai, India). Buffer was prepared by dissolv-
ing 1360 mg (10 mM) of potassium dihydrogen orthophos-
phate and 3330 mg of TBAH (10 mM) in 1 L of HPLC
grade water.
Table 1 Hydrolytic, oxidative, thermal and photolytic stress testing conditions for EBZ.
Stress condition Solvent Temperature (C) Time (days) Sampling time (days)
Hydrolytic
Neutral H2O 60 25 1,2,3,4,6,7,11,14,25
Acidic 2 N HCl 60 30 1,2,3,4,6,7,11,14,25,30
5 N HCl 60 30 1,2,3,4,6,7,11,14,25,30
Basic 2 N NaOH 60 30 1,2,3,4,6,7,11,14,25,30
5 N NaOH 60 30 1,2,3,4,6,7,11,14,25,30
Oxidizing 3% H2O2 Room temperature 7 1,2,3,4,6,7
10% H2O2 Room temperature 7 1,2,3,4,6,7
Thermal
Moist heat Methanol 60 14 1,2,3,4,6,7,11,14
Dry heat Methanol 60 14 1,2,3,4,6,7,11,14
Photolytic
Direct sunlight Methanol – 25 1,2,3,4,6,7,11,14,25
Table 2 Factors and levels used in the experimental design.
Factor Level (1) Level (0) Level (+1)
TBAH (mM) 5 7.5 10
pH 2.6 2.9 3.2
Organic phase (v/v) 20 25 30
Quality by Design (QbD) approach to develop HPLC method for eberconazole nitrate: Application S3152.2. HPLC instrumentation and chromatographic conditions
The HPLC system consisted of two pumps (Analytical Tech-
nologies P2230 HPLC pump), a manual injector with 20 lL
capacity per injection, and a temperature-controlled column
oven. The UV–vis detector (Analytical Technologies UV
2230) was operated at a wavelength of 220 nm. The software
used was chromatography workstation A-2000, version 1.6.
Columns used were Lichrospher C 18, 250 mm · 4.6 mm,
5.0 lm (Merck, Germany), Atlantis C 18, 250 mm · 4.6 mm,
5.0 lm (Waters Corporation, USA) and Alltima C-8,
250 mm · 4.6 mm, 5.0 lm (Grace, USA).Pareto Chart of Standardized Effects; Variable: Capacity Factor
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Figure 3 Pareto graph to show the inﬂuence of variables on the
capacity factor of EBZ.Chromatographic separation of EBZ was achieved at
ambient temperature using a Lichrospher RP C18
(250 mm · 4.6 mm, 5 lm) analytical column; the mobile phase
consisted of methanol–potassium dihydrogen orthophosphate
(pH 2.8; 10 mM, tetra butyl ammonium hydroxide; 10 mM)
(25:75, v/v) at a ﬂow rate of 1.0 mL min1. pH of buffer was
adjusted with o-phosphoric acid. Before use, the mobile phase
was ﬁltered through a 0.22 lm nylon membrane ﬁlter and son-
icated for 15 min. Injection volume was 20 lL, and the opti-
mum wavelength selected for quantiﬁcation was 220 nm.
2.3. Construction of the calibration curve
Standard stock solution of EBZ was prepared in methanol at a
concentration of 10 mg mL1 and further diluted with the mo-
bile phase to furnish the working standard stock solution of
100 lg mL1. The working standard stock solution was diluted
with the mobile phase to prepare calibration samples in the
concentration range of 0.5–100 lg mL1. Triplicate injections
of 20 lL were made for each calibration sample and chromato-
graphed under the speciﬁed HPLC conditions described previ-
ously. Peak areas were plotted against the corresponding
concentration to obtain the calibration curve.
2.4. Forced degradation of EBZ
2.4.1. Hydrolytic conditions: acid, alkali and water induced
degradation
Standard stock solution (1 mL) was transferred to each of ﬁve
10 mL volumetric ﬂasks and the volume was made up to the
mark with 2 N HCl, 5 N HCl, 2 N NaOH, 5 N NaOH and
water separately. These were subjected to the conditions spec-
iﬁed in Table 1.
2.4.2. Oxidizing conditions: hydrogen peroxide-induced
degradation
Standard stock solution (1 mL) was transferred to each of two
10 mL volumetric ﬂasks and the volume was made up to the
mark with 3% H2O2 and 10% H2O2 separately. These were
subjected to the conditions speciﬁed in Table 1.
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Figure 5 Contour plot for capacity factor as a function of
TBAH concentration and organic phase.
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Figure 6 Contour plot for capacity factor as a function of pH
and organic phase.
S316 M.V. Krishna et al.2.4.3. Thermal conditions: dry heat and moist heat induced
degradation
Standard stock solution (1 mL) was transferred to each of two
10 mL volumetric ﬂasks and the volume was made up to the
mark with methanol. These were subjected to the conditions
indicated in Table 1.
2.4.4. Photolytic degradation: exposure to sun light
Standard stock solution (1 mL) was transferred to a 10 mL
volumetric ﬂask and the volume was made up to the mark with
methanol. This was subjected to the conditions mentioned in
Table 1.
2.5. Sample collection, storage and preparation
Before collecting samples, the volume was made up to the
mark with respective solvent. Sample (200 lL) was collected
at speciﬁed sampling points as indicated in Table 1. The sam-
ples from acid and base induced degradation were neutralized
by adding 200 ll of appropriate strength of NaOH and HCl.
All samples were stored at 2–8 C in the refrigerator. On the
day of analysis samples were diluted with the mobile phase
up to 10 mL, ﬁltered with a 0.22 lm membrane syringe ﬁlter
and injected three times for each sample into HPLC.
3. Results and discussion
3.1. Method development and optimization
Optimum wavelength of 220 nm was selected to reduce the
base line noise at absorption maximum (208 nm) of EBZ.
Based on EBZ solubility, methanol was selected as organic
phase. Initially, reversed-phase analytical columns (C18 and
C8) were tested with mobile phase composed of variable com-
position of methanol (80–20% v/v) and water. Then water was
replaced with buffer (10 mM potassium dihydrogen ortho-
phosphate) at different pH levels ranging from 2.5 to 6.0 with
a ﬂow rate of 1 mL min1. In the above employed conditions;
EBZ did not get any capacity factor (k). EBZ was eluted along
with the mobile phase, i.e. the retention volume was equal toFitted Surface; Variable: Capacity Factor
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Figure 4 Contour plot for capacity factor as a function of
TBAH concentration and buffer pH.
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Figure 7 Normal probability plot of residuals for capacity
factor.
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Figure 8 Plot of residuals versus predicted response for capacity
factor.
Figure 9 Representative chromatograms of EBZ blank (A),
standard (B) and formulation (C).
Table 3 Stability of EBZ in the mobile phase.
Time (h) Peak area (60 lgmL1 of EBZ)
0 749
3 742
6 749
9 756
12 761
24 760
Mean ± SD, RSD (%), n= 6 752.83 ± 7.41, 0.98.
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basic drug having pKa of 6.2, we employed ion pair methodol-
ogy, using TBAH as an ion pair agent at the concentration of
10 mM. pH of the buffer (10 mM potassium dihydrogen
orthophosphate) was adjusted to 3.2 with o-phosphoric acid,
i.e., more than two units below the pKa (6.2) to ionize EBZ
by 100%. Based on the above conditions, the mobile phase
composed of methanol: buffer at the 30:70 ratio eluted EBZ
through the C18 stationary phase (Lichrospher, RP C18,250 mm · 4.6 mm, 5 l) having a k of 1.44. In order to get a
satisfactory k between 2 and 3, pH of buffer was varied between
2.6 and 3.2, level of methanol was varied between 20% and
30% v/v and TBAH concentration was varied between 5 and
10 mM. Twenty-seven experiments were conducted using the
full factorial design (3 factors, 3 levels, 27 runs), in order to
rationally examine the effects of TBAH concentration, buffer
pH and organic phase concentration on the capacity factor
of EBZ. Experimental factors and levels used in the experimen-
tal design are shown in Table 2. The factors and ranges
selected for consideration were based on previous univariate
studies and chromatographic intuition. The data generated
were analyzed using Statistica (Version 6.0).
Fig. 3 shows the inﬂuence of each factor on the capacity
factor. Organic phase and TBAH were signiﬁcant by linear
regression; by quadratic regression only organic phase was
signiﬁcant and TBAH effect was smaller. Effect of pH was
non-signiﬁcant by both linear and quadratic regression. Two-
dimensional contour plots are presented in Figs. 4–6 and are
very useful for studying the interaction effects of the factors
on the capacity factor. Capacity factor of EBZ increases as
the TBAH concentration increases (Fig. 4). Fig. 5 shows that
increase in TBAH concentration increases the capacity factor
and increase in organic phase concentration decreases the
capacity factor. The effect of pH on the capacity factor of
EBZ was investigated in a pH range of 2.6–3.2; as can be seen
from the contour plots (Figs. 4 and 6), it has no effect on
capacity factor.
The model that has been developed can be used to predict
the capacity factor of EBZ within the limits of the experiments.
The normal probability plot of the residuals and the plot of the
residuals versus the predicted response for capacity factor are
shown in Figs. 7 and 8. Close inspection of Fig. 7 reveals that
the residuals generally fall on a straight line which indicates
that the errors are normally distributed, thus supporting the
fact that the model ﬁts the data adequately. These plots are
very important and are required to check the normality
assumption in a ﬁtted model. This will ensure that the model
provides an adequate approximation to the optimization pro-
cess. It is clear that there is no obvious pattern followed in the
residual versus predicted response as shown in Fig. 8. The plot
reveals an almost equal scatter above and below the X-axis,
implying that the proposed model is adequate and there is
no reason to suspect any violation of the independence or con-
stant variance assumption.
The optimized chromatographic conditions obtained from
the design were mixture of 10 mM potassium dihydrogen
orthophosphate (pH 2.8) containing 10 mM TBAH and
methanol (25:75, v/v), at a ﬂow rate of 1.0 mL min1. These
chromatographic conditions achieved reasonable retention
(k= 2.06) and symmetric peak shape for EBZ with a retention
time of 7.05 min (Fig. 9). No interference from the blank and
cream formulation excipients was observed at the retention
time of EBZ (Fig. 9). Percentage of recovery (n= 6) obtained
from the formulation was 100.5 ± 1.8.3.2. Solution stability
The stability of EBZ in the mobile phase was investigated by
analyzing the standard of EBZ (60 lg mL1) at 0, 3, 6, 9, 12
and 24 h. No signiﬁcant variation in the peak area of standard
[Minutes]
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Figure 10 A model chromatogram of EBZ under acidic stress
condition.
Table 4 System suitability data.
Property Mean ± SD, n= 6 RSD (%) Required limits
Retention time (Rt) 7.05 ± 0.04 0.56 RSD 6 2%
Capacity factor (k) 2.06 ± 0.004 0.19 –
Theoretical plates (N) 32772 ± 182 0.55 N > 2000
Tailing factor (T) 1.31 ± 0.02 1.52 T 6 2
Table 5 Recovery of the standard from stress degraded samples by standard addition method.
Level of
standard
added (%)
Amount of
standard
added (lg)
Sample Mean peak area ± SD, RSD (%) (n= 3) Amount of
standard found (lg)
Recovery for
standard (%)
Standard + Sample Standard
80 40 1425.61 ± 15.24, 1.06 1930.53 ± 18.85, 0.90 504.92 ± 5.74, 1.13 40.02 100.05
100 50 1453.28 ± 16.31, 1.12 2079.12 ± 23.25, 1.11 625.84 ± 6.86, 1.09 50.05 100.1
120 60 1486.61 ± 16.56, 1.11 2240.32 ± 26.21, 1.16 753.71 ± 9.15, 1.21 60.01 100.02
Table 6 Results of intra-day and inter-day precision.
Concentration Intra-day precision Inter-day precision
Peak area Peak area
(lg mL1) Mean ± SD (n= 6) RSD (%) Mean ± SD (n= 6) RSD (%)
10 140.50 ± 1.64 1.16 137.22 ± 2.28 1.66
40 528.16 ± 5.94 1.12 533.57 ± 6.93 1.30
60 713.16 ± 7.78 1.09 729.19 ± 13.02 1.78
80 938.33 ± 10.65 1.13 968.12 ± 16.69 1.72
S318 M.V. Krishna et al.solution was observed (Table 3) and also no additional peaks
were found in the chromatogram, indicating that EBZ was sta-
ble in the mobile phase.3.3. Method validation
To conﬁrm the suitability of the method for its intended pur-
pose, the method was validated in accordance with the ICH
guidelines (ICH guideline Q2 (R1), 2005) for system suitability,
linearity, limits of detection and quantiﬁcation, accuracy, in-
tra-day and inter-day precision, speciﬁcity and robustness.3.3.1. System suitability
System-suitability test was an integral part of method develop-
ment and has been used to ensure adequate performance of the
chromatographic system. Retention time (Rt), capacity factor
(k), number of theoretical plates (N) and tailing factor (T),
were evaluated for six replicate injections of the drug at a con-
centration of 60 lg mL1. The results presented in Table 4 are
within the acceptable limits.3.3.2. Linearity
Linearity of the proposed method was evaluated according
to the ICH guidelines. EBZ showed linearity in the concentra-
tion range of 10–80 lg mL1, (r2 = 0.999). The regression
equation obtained was Y= 12.50X+ 1.785, where Y is peak
area and X is concentration of EBZ (lg mL1). This equation
was used to determine the amount of EBZ present in the stabil-
ity samples.3.3.3. Limits of detection and quantiﬁcation
The limit of detection (LOD) was deﬁned as the lowest concen-
tration of EBZ resulting in a signal-to-noise ratio of 3:1 and
limit of quantiﬁcation (LOQ) was expressed as a signal-to-
noise ratio of 10:1. Due to the difference in detector response,
different concentrations ranging from 0.01 to 2 lg mL1 were
prepared and analyzed. The LOD and LOQ obtained were 0.3
and 0.9 lg mL1, respectively.
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Figure 11 Amodel chromatogram of EBZ under oxidative stress
condition.
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Accuracy of the method was determined by performing the
recovery experiments. Known amount of the standard at
80%, 100% and 120% levels was fortiﬁed to the degradation
sample. Peak area of the standard was calculated by the
difference of peak area between fortiﬁed and unfortiﬁed sam-
ples. Three replicate samples of each concentration level were
prepared and the percentage recovery at each level (n= 3)
was determined (Table 5). For EBZ, the results obtained are
in good agreement with the added amounts.
3.3.5. Intra-day and inter-day precision
Intra-day and inter-day precision was evaluated by injecting
four different concentrations (10, 40, 60, and 80 lg mL1) of
EBZ. For intra-day variation, sets of six replicates of the four
concentrations were analyzed on the same day; for inter-day
variation, six replicates were analyzed on six different days.
The intra-day and inter-day precision (%RSD) was found to
be less than 2% (Table 6), indicating that the method was
precise.Table 7 Results for the analysis of robustness.
Factors Level Retention time (
Mean ± SD (n=
A: Flow rate (mL min1)
0.9 1 7.09 ± 0.02
1.0 0 7.05 ± 0.02
1.1 +1 6.99 ± 0.03
Mean 7.04 ± 0.03
B: Percentage of methanol in the mobile phase (v/v)
23 1 7.11 ± 0.06
25 0 7.05 ± 0.07
27 +1 6.99 ± 0.06
Mean 7.05 ± 0.06
C: pH of buﬀer
2.7 1 7.05 ± 0.06
2.8 0 7.05 ± 0.04
2.9 +1 7.03 ± 0.03
Mean 7.04 ± 0.04
D: Columns from diﬀerent manufacturers
(I) Lichrospher C18 column 7.05 ± 0.08
(II) Atlantis C18 column 7.03 ± 0.04
Mean 7.04 ± 0.063.3.6. Speciﬁcity
Speciﬁcity is the ability to measure accurately and speciﬁcally
the analyte of interest in the presence of other components that
may be expected to be present in the sample matrix. The spec-
iﬁcity of the HPLC method was illustrated in Figs. 10 and 11,
where complete separation of EBZ was noticed in the presence
of degradants. The average Rt± standard deviation for EBZ
was found to be 7.05 ± 0.04 min, for six replicates. The peaks
obtained were sharp and had clear baseline separation.
3.3.7. Robustness
A method is robust if it is unaffected by small changes in oper-
ating conditions. To evaluate HPLC method’s robustness few
parameters were deliberately varied. The parameters included
variation of C18 columns from different manufacturers, pH
of the buffer, ﬂow rate and percentage of methanol in the mo-
bile phase. Two analytical columns were used during the exper-
iment, one from Germany (Lichrospher C 18 column) and the
other from USA (Atlantis C 18 column). Each of the three
examined factors (pH, ﬂow rate, and methanol percentage) se-
lected was changed one at a time to estimate the effect. Repli-
cate injections (n= 6) of standard solution (60 lg mL1) were
performed under small changes of chromatographic parame-
ters (factors). Flow rate was varied by 1 ± 0.1 mL min1; level
of methanol in the mobile phase was varied by 25 ± 2% (v/v),
while pH was varied by 2.8 ± 0.1. Results obtained are pre-
sented in Table 7, indicating that the results remained unaf-
fected by small variations of these parameters. The results
from the two columns indicated that there is no signiﬁcant dif-
ference between the results from the two columns.
3.4. Stability-indicating property
An analytical method is stability-indicating if this method can
separate all the process-related impurities and all the degrada-min) Tailing factor Peak area
6) Mean ± SD (n= 6) Mean ± SD (n= 6)
1.35 ± 0.04 758.24 ± 8.45
1.31 ± 0.03 751.45 ± 10.34
1.31 ± 0.03 749.12 ± 9.86
1.32 ± 0 .03 752.6 ± 9.58
1.30 ± 0.02 756.65 ± 7.28
1.32 ± 0.03 752.87 ± 6.57
1.31 ± 0.02 748.34 ± 8.43
1.31 ± 0.02 752.62 ± 9.86
1.30 ± 0.02 752.45 ± 7.22
1.33 ± 0.04 755.88 ± 6.16
1.36 ± 0.03 753.58 ± 8.65
1.33 ± 0.03 753.95 ± 7.35
1.34 ± 0.04 754.52 ± 7.24
1.32 ± 0.03 749.67 ± 8.68
1.33 ± 0.03 752.09 ± 7.86
Cl
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Scheme 1 Proposed degradation mechanism of EBZ under (a) hydrolytic/thermal/photolytic stress conditions (b) oxidative stress
conditions.
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Figure 12 First order plots for the degradation of EBZ under acidic and basic stress conditions (each point represents the mean ± SD,
n= 3).
S320 M.V. Krishna et al.tion products from the major peak of the sample. The model
chromatograms of EBZ under acidic and oxidative stress con-2 
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Figure 13 First order plots for the degradation of EBZ under
thermal stress conditions (each point represents the mean ± SD,
n= 3).ditions are presented in Figs. 10 and 11. EBZ under acidic and
basic stress conditions showed same degradant peaks at the
retention time of 2.8, 4.1 and 7.9 min. Stress samples under
dry heat, moist heat, water hydrolysis and photolysis showed
two degradant peaks at 2.8 and 4.1 min. Under oxidative stress
conditions, EBZ showed two degradant peaks at 2.8 and
6.0 min; the peak observed at 3.1 min corresponds to the
blank. This indicates that the drug is susceptible to hydrolytic
(acid, base and water), oxidative, thermal and photolytic deg-
radation. In all the above cases the degradant peaks did not
interfere with the EBZ peak, suggesting that the method en-
abled speciﬁc analysis of EBZ in the presence of its degrada-
tion products. Scheme 1 presents the proposed degradation
mechanism of EBZ in different stress conditions. 2,4-di-
chloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ol (I) and
Imidazole (III) might be the major degradation products in
hydrolytic/thermal/photolytic stress conditions; 2,4-dichloro-
10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one (II) and
Imidazole (III) might be the degradation products in oxidative
stress conditions.
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Figure 14 First order plots for the degradation of EBZ under oxidative stress conditions (each point represents the mean ± SD, n= 3).
Quality by Design (QbD) approach to develop HPLC method for eberconazole nitrate: Application S3213.5. Kinetic investigation
Treatment of EBZ under speciﬁed stress conditions resulted in
a gradual decomposition of EBZ in all conditions. Since the
degradation was performed with a large excess of solvent
(9 mL) compared to drug solution (1 mL), the degradation
of EBZ followed pseudo-ﬁrst-order kinetics (Florence and Att-
wood, 1998) as a linear relationship between log percentage of
EBZ remaining and time was established, having good correla-
tion coefﬁcients (Figs. 12–15). Pseudo-ﬁrst-order is the term
used when two reactants are involved in the reaction but one
of them is in such a large excess that any change in its concen-
tration is negligible compared with the change in concentration
of the other reactant (drug). The kinetic parameters are2 
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Figure 15 First order plots for the degradation of EBZ under
hydrolytic and photolytic stress conditions (each point represents
the mean ± SD, n= 3).presented in Table 8. Rate constant (K), time left for 50% po-
tency (t1/2) and time left for 90% potency (t90) for each stress
condition were calculated using Eqs. (1)–(3), respectively (Con-
nors et al., 1986):log½Ct ¼ log½C0  Kt
2:303
ð1Þ
t1=2 ¼ 0:693
K
ð2Þ
t90 ¼ 0:105
K
ð3Þ
where K is the rate constant, [C0] is the concentration of EBZ
at time t= 0 and [Ct] is its concentration at time t.
The K values per day were found to be 3.48 · 103,
19.18 · 103, 6.78 · 103, 19.84 · 103, 12.14 · 103,
63.79 · 103, 30.69 · 103, 23.53 · 103, 20.20 · 103 and
21.72 · 103 for 2 N NaOH, 5 N NaOH, 2 N HCl, 5 N HCl,
3% H2O2, 10% H2O2, dry heat, moist heat, water hydrolysis
and photolytic conditions, respectively. The rate constant val-
ues were increased as the strength of NaOH, HCl and H2O2 in-
creased. K value was increased approx. six times as the
strength of NaOH was increased from 2 N to 5 N, while the
rate of degradation was increased up to approx. three times
under the same conditions of acid (HCl) treatment, indicating
more susceptibility of EBZ under basic media compared to
acidic. The K value for water induced degradation was found
to be similar to the degradation by 5 N HCl and 5 N NaOH,
specifying the importance of water toward EBZ degradation.
Between thermal treatments K value for dry heat was found
to be higher than moist heat. Extensive degradation was ob-
served in oxidative conditions, where K value was found to
be highest among all the tested conditions. Hence the effect
of oxygen needs to be considered for topical formulation of
EBZ. Suitable antioxidants need to be a part of the topical for-
mulation of EBZ. K value obtained for photolytic degradation
was similar to water hydrolysis, 5 N NaOH and 5 N HCl. This
illustrates the prominent effect of light toward the stability of
EBZ. t1/2 and t90 values for all the tested stress conditions are
shown in Table 8, both t1/2 and t90 were found to be lowest
(10.86 and 1.65 days) for oxidative condition (10% H2O2)
Table 8 Summary of EBZ degradation kinetics.
Stress condition K (day1)a t1/2 (days)
b t90 (days)
c Degraded (%)
2 N NaOH 3.48 · 103 198.99 30.24 9.64
5 N NaOH 19.18 · 103 36.13 5.49 43.39
2 N HCl 6.78 · 103 102.23 15.53 18.87
5 N HCl 19.84 · 103 34.93 5.31 43.72
3% H2O2 12.14 · 103 57.06 8.67 7.08
10% H2O2 63.79 · 103 10.86 1.65 32.24
Dry heat 30.69 · 103 22.58 3.43 32.49
Moist heat 23.53 · 103 29.45 4.47 27.26
Hydrolysis 20.20 · 103 34.31 5.21 39.57
Photolysis 21.72 · 103 31.91 4.85 41.53
a Rate constant per day.
b Half-life.
c Time left for 90% potency.
S322 M.V. Krishna et al.and highest (198.99 and 30.24 days) for alkaline hydrolysis
with 2 N NaOH.4. Conclusion
The proposed HPLC method provides simple, accurate and
reproducible quantitative analysis for the determination of
EBZ in the presence of its degradants. It was found that
EBZ was rapidly degraded under oxidative, hydrolytic (acid
and alkali) and photolytic conditions. The degradation of
EBZ was found to be of pseudo-ﬁrst-order kinetics in analyte’s
concentration. The reaction rate increases with increase in
strength of the acid/base/H2O2 solution. This study suggests
that the formulation scientist needs to incorporate antioxi-
dants in the topical formulation of EBZ and also care
should be taken to prevent photolysis upon its exposure to
sun light.
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